Novo Holdings Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 73

Professionals
  • Investments
  • 501

  • Portfolio
  • 134

  • Exits
  • 205

Exits

Novo Holdings General Information

Description

Founded in 1999, Novo Holdings is a venture capital firm based in Copenhagen, Denmark. The firm prefers to invest in biotech, pharma, medtech, bioindustrials, and services.

Contact Information

Formerly Known As
Nova A/S
Year Founded
1999
Investor Status
Actively Seeking New Investments
Trade Association
Danish Venture Capital Association (DAVCA)
National Venture Capital Association (NVCA)
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
  • Tuborg Havnevej 19
  • 2900 Hellerup
  • 2900 Copenhagen
  • Denmark
+45 35 00 00 00

Novo Holdings Investments & Acquisitions (501)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Engimmune Therapeutics 03-May-2022 Seed Round 000.00 Drug Discovery Generating Revenue 0ø0000 0ø0000 00000000 00.0
0000.00 29-Mar-2022 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue 0000 00000 00
000000 28-Mar-2022 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1 000000 0000000000000
00000000 16-Mar-2022 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 000000 0ø00000
00000000 28-Feb-2022 00000 00000 0000 Building Products Generating Revenue 000000 00000 00.0
00000 000000000000 22-Feb-2022 00000 00000 0000 Biotechnology Generating Revenue
000 00000000 18-Feb-2022 0000000000 Pharmaceuticals Profitable 00000000 0000
00000000 000000000 16-Feb-2022 00000 00000 000.00 Drug Discovery Generating Revenue 0000000 000000 00.0
NMD Pharma 15-Feb-2022 Later Stage VC 000.00 Drug Discovery Generating Revenue 000000 0ø00000
Vestaron 09-Feb-2022 Later Stage VC 0000 Agricultural Chemicals Generating Revenue 000000 0000000000000
You’re viewing 10 of 501 investments and acquisitions. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novo Holdings Exits (205)

Company Name Exit Date Exit Type Exit Size
Arcellx 16-Jun-2022 Public Investment 2nd Offering 00000
0000000 09-Jun-2022 000000000000000000 00000
000000000 00000000 31-May-2022 000000000000000000 00000
000000 00000000000 28-Apr-2022 000000 0000000000 00000
0000000 0000000000 25-Feb-2022 000000000000000000 000
0000000 04-Feb-2022 000 00000
0000000 000000 13-Dec-2021 000000000000000000 00000
00 0000000 05-Nov-2021 000 00000
Minerva (Therapeutic Devices) 26-Oct-2021 IPO 0000
Exscientia 01-Oct-2021 IPO 00000
You’re viewing 10 of 205 exits. Get the full list »

Novo Holdings Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Novo Holdings Team (146)

Name Title Deals Funds Boards Office
Kasim Kutay Chief Executive Officer 0 0 0 San Francisco, CA
Christoffer Søderberg Managing Partner & Head of Principal Investments. 0 0 0 Copenhagen, Denmark
Morten Beck Jørgensen Managing Partner, Financial Investments 0 0 0 Copenhagen, Denmark
Søren Moller Ph.D Managing Partner, Novo Seeds 00 0 0 Copenhagen, Denmark
Scott Beardsley Managing Partner, Novo Ventures (US) San Francisco, CA
You’re viewing 5 of 146 team members. Get the full list »

Novo Holdings Co-Investors (465)

Name With Exits Lead Partner Series Industry
RA Capital Management 11 00 Series chart Industry bar
OrbiMed 0 0 00 Series chart Industry bar
Rock Springs Capital 0 0 Series chart Industry bar
Vivo Capital 0 0 0 Series chart Industry bar
Citadel Enterprise Americas 0 0 Series chart Industry bar
You’re viewing 5 of 465 co-investors. Get the full list »